Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 5, 2005, Pages 836-840

  Culebras, Esther ^a   Rodríguez Avial, Iciar ^a   Betriu, Carmen ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Clindamycin resistance; Gene regulation; Group B streptococci

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CLINDAMYCIN; DNA FRAGMENT; ERYTHROMYCIN; PROTEIN ERM; SIGNAL PEPTIDE; TRANSPOSASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; ERYTHROMYCIN RESISTANCE METHYLASE GENE; GENE EXPRESSION REGULATION; GENE INSERTION; GENETIC EPIDEMIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STREPTOCOCCUS AGALACTIAE; TRANSLATION INITIATION;

5' UNTRANSLATED REGIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CLINDAMYCIN; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ERYTHROMYCIN; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 27744480009     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki337     Document Type: Article

References (22)

1. Schrag S, Gorwitz R, Fultz-Butts K et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1-22.
2. Betriu C, Culebras E, Gomez M et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 2003; 47: 1112-4.
3. Murdoch DR, Reller LB. Antimicrobial susceptibility of group B streptococci isolated from patients with invasive disease: 10-years perspective. Antimicrob Agents Chemother 2001; 45: 1040-4.
4. Giovanetti E, Brenciani A, Burioni R et al. A novel efflux system in inducible erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother 2002; 46: 3750-5.
5. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
6. Roberts MC, Sutcliffe J, Courvalin P et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823-30.
7. Fitoussi F, Loukil C, Gros I et al. Mechanisms of macrolide resistance in clinical group B Streptococci isolated in France. Antimicrob Agents Chemother 2001; 45: 1889-91.
8. Seppälä H, Nissinen A, Yu Q et al. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-91.
9. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
10. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-6.
11. Seppälä H, Skurnik M, Soini H et al. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257-62.
12. Culebras E, Rodríguez-Avial I, Betriu C et al. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother 2002; 46: 1574-6.
13. Fines M, Gueudin M, Ramon A et al. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. J Antimicrob Chemother 2001; 48: 411-6.
14. Seppälä H, He Q, Österblad M et al. Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol 1994; 32: 1945-8.
15. Tettelin H, Masignani V, Cieslewicz MJ et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA 2002; 99: 12391-6.
16. Rosato A, Vicarini H, Leclercq R. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J Antimicrob Chemother 1999; 43: 559-62.
17. Werckenthin C, Schwarz S. Molecular analysis of the translational attenuator of a constitutively expressed erm(A) gene from Staphylococcus intermedius. J Antimicrob Chemother 2000; 46: 785-8.
18. Murphy E. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J Bacteriol 1985; 162: 633-40.
19. Walsh F, Willcock J, Amyes S. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J Antimicrob Chemother 2003; 52: 345-53.
20. Doktor SZ, Shortridge V. Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance. Antimicrob Agents Chemother 2005; 49: 3070-2.
21. Malhotra-Kumar S, Mazzariol A, Lammens C et al. Unusual resistance patterns related to alterations in the erm(A) attenuator in macrolide-resistant (MAC-R) Streptococcus pyogenes (SPY). In: Programs and Abstracts of the Forty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, 2004. Abstract C1-411, p. 68. American Society for Microbiology, Washington, DC, USA.
22. Tamura GS, Herndon M, Przekwas J et al. Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis 2000; 181: 364-8.